Renal Insufficiency, Chronic: all 3,224 studies

Page 12 of 33. Open to participants first (706), then studies with results posted, then the rest; newest registration first within each.

• Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 YearsCompletedNCT01073462Results posted
• Evaluate Safety and Efficacy of Paricalcitol in Reducing Serum Intact Parathyroid Hormone in Chronic Kidney DiseaseCompletedNCT01071070Phase 3Results posted
• Handgrip Exercise for Arteriovenous Fistula MaturationCompletedNCT01061008Not applicableResults posted
• A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney DiseaseCompletedNCT01052779Phase 2Results posted
• A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With HyperphosphatemiaCompletedNCT01039428Phase 2Results posted
• Exercise in Obese Diabetic Patients With Chronic Kidney DiseaseCompletedNCT01036490Not applicableResults posted
• The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney DiseaseCompletedNCT01029002Phase 3Results posted
• Safety and Efficacy of Paricalcitol Capsules in Decreasing Serum Parathyroid Hormone Levels in Children Aged 10-16 With Chronic Kidney Disease (CKD)CompletedNCT01020487Phase 3Results posted
• Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney DiseaseTerminatedNCT01012414Phase 3Results posted
• Study of the Pharmacokinetics of Daptomycin in Children With Renal DiseaseCompletedNCT01012089Not applicableResults posted
• Intradialytic Progressive Resistance Training for Maintenance Haemodialysis PatientsCompletedNCT01007838Not applicableResults posted
• Metabolic Effects of ParicalcitolCompletedNCT01003275Phase 2Results posted
• The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney DiseaseCompletedNCT01002872Not applicableResults posted
• FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney DiseaseCompletedNCT00999037Not applicableResults posted
• Clinical Evaluation of Ropinirole IR (Immediate Release) Tablets in Patients Who Are Diagnosed With Symptomatic Restless Legs Syndrome (RLS) Associated With Chronic Kidney Disease (CKD) Managed With Haemodialysis (Including Haemofiltration and Haemodiafiltration)TerminatedNCT00996944Phase 2Results posted
• Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)CompletedNCT00994318Phase 3Results posted
• Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary HyperparathyroidismCompletedNCT00990704Phase 2Results posted
• Comparing Safety and Immunogenicity of HEPLISAV-B® to Engerix-B® in Chronic Kidney Disease (CKD) PatientsCompletedNCT00985426Phase 3Results posted
• Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin DCompletedNCT00977080Phase 4Results posted
• Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant RecipientsCompletedNCT00975000Phase 3Results posted
• A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002)TerminatedNCT00968617Phase 2Results posted
• Study of How the Dose of Dialysis is Affected by Dialysate Flow RateCompletedNCT00962000Not applicableResults posted
• Chronic Kidney Disease Antidepressant Sertraline TrialCompletedNCT00946998Phase 3Results posted
• Evaluation of Monthly Darbepoetin Alfa Dosing for Correction of Anemia in Non-dialysis Chronic Kidney DiseaseCompletedNCT00925587Phase 3Results posted
• A Study of the Efficacy and Safety of MK2578 for the Treatment of Anemia in Patients With Kidney Disease (MK2578-003-AM03-EXT12)TerminatedNCT00924781Phase 2Results posted
• Chronic Kidney Disease (CKD) Guideline Adherence - A Quality Improvement StudyCompletedNCT00921687Not applicableResults posted
• Vascular Reactivity in Chronic Kidney Disease (CKD) Patients Receiving Paricalcitol Versus PlaceboCompletedNCT00915876Not applicableResults posted
• Post-marketing Safety Study in Patients With Moderate Renal Insufficiency Who Receive Omniscan for Contrast-enhanced Magnetic Resonance Imaging (MRI)CompletedNCT00908310Phase 4Results posted
• Inflammation in Chronic Kidney Disease and Cardiovascular Disease - The Role of Genetics and Interleukin-1 Receptor Antagonist (IL-1ra)CompletedNCT00897715Phase 2Results posted
• Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial DoseCompletedNCT00891813Phase 4Results posted
• Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial EffectsCompletedNCT00888290Phase 2/3Results posted
• Myocardial Glucose Uptake (MGU) in Patients With Chronic Kidney DiseaseCompletedNCT00883415Results posted
• Med-alert Bracelet in Chronic Kidney DiseaseCompletedNCT00883389Results posted
• Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney DiseaseCompletedNCT00874432Phase 2Results posted
• Efficacy and Safety Study of MCI-196 Versus Simvastatin for Dyslipidaemia in Chronic Kidney Disease (CKD) Subjects on DialysisCompletedNCT00858637Phase 3Results posted
• Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on HemodialysisCompletedNCT00853242Phase 2Results posted
• Niacin and Endothelial Function in Early CKDCompletedNCT00852969Phase 4Results posted
• Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)CompletedNCT00843349Not applicableResults posted
• European Union Registry in Paediatric Chronic Kidney Disease Patients Looking at Safety and Usage Patterns of Darbepoetin AlfaCompletedNCT00838097Results posted
• Severe Renal Disease Study in Fabry Patients Treated With FabrazymeTerminatedNCT00837824Phase 2Results posted
• A Clinical Trial of Oral Versus IV Iron in Patients With Chronic Kidney DiseaseTerminatedNCT00830037Phase 4Results posted
• Study of Phosphate Levels in Patients With Chronic Kidney DiseaseCompletedNCT00824460Phase 2Results posted
• Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)CompletedNCT00823303Phase 4Results posted
• Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease SubjectsCompletedNCT00810732Phase 2Results posted
• Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney DiseaseCompletedNCT00806676Not applicableResults posted
• 20070360 Incident DialysisCompletedNCT00803712Phase 4Results posted
• Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background InclusiveCompletedNCT00800683Phase 3Results posted
• A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKDCompletedNCT00785629Not applicableResults posted
• Renal Safety of Iopamidol Versus Iodixanol During Coronary Angiography in Diabetic PatientsTerminatedNCT00782639Phase 4Results posted
• A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)CompletedNCT00773513Phase 4Results posted
• Vitamin D Repletion in Chronic Kidney DiseaseCompletedNCT00772772Early Phase 1Results posted
• Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With HyperphosphatemiaCompletedNCT00772382Phase 3Results posted
• Phase 2 Study of Roxadustat in Participants With Anemia and Chronic Kidney Disease Not Requiring DialysisCompletedNCT00761657Phase 2Results posted
• Vitamin D and Coronary Calcification StudyCompletedNCT00752102Phase 4Results posted
• A Study of Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal DialysisCompletedNCT00737477Phase 3Results posted
• LEARN-6™: A Prospective, Observational Nursing Home StudyCompletedNCT00727571Results posted
• Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on HemodialysisCompletedNCT00717366Phase 2Results posted
• Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)CompletedNCT00701805Phase 2Results posted
• Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis PatientsTerminatedNCT00701714Phase 3Results posted
• Safety & Efficacy of Peginesatide for Treatment of Anemia in Participants on Dialysis Not Receiving an ESACompletedNCT00680043Phase 2Results posted
• 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney DiseaseCompletedNCT00680017Phase 3Results posted
• Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving HemodialysisCompletedNCT00667576Phase 2Results posted
• Testosterone Replacement Therapy in Advanced Chronic Kidney DiseaseCompletedNCT00645658Not applicableResults posted
• Carvedilol and Micro T-Wave Alternans in Hypertensives With Chronic Kidney DiseaseTerminatedNCT00638222Not applicableResults posted
• Molecule Removal and Ease of Use: A Comparison of Two Different DialyzersCompletedNCT00636389Not applicableResults posted
• Comparative Effects Of Dialysate Flow Rate And Membrane Packing On The Performance Of Dialyzers Used For HemodialysisCompletedNCT00636077Not applicableResults posted
• Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v.CompletedNCT00632125Phase 4Results posted
• Tetrahydrobiopterin in Patients With Chronic Kidney Disease (CKD) and AlbuminuriaCompletedNCT00625820Phase 2Results posted
• The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5TerminatedNCT00616902Phase 3Results posted
• Safety and Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on DialysisCompletedNCT00598442Phase 3Results posted
• Safety & Efficacy of Peginesatide for the Treatment of Anemia in Participants With Chronic Renal Failure Not on DialysisCompletedNCT00598273Phase 3Results posted
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on HemodialysisCompletedNCT00597753Phase 3Results posted
• Safety & Efficacy of Peginesatide for Maintenance Treatment of Anemia in Participants With Chronic Kidney Disease on HemodialysisCompletedNCT00597584Phase 3Results posted
• Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal FunctionTerminatedNCT00586261Not applicableResults posted
• A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Participants With Chronic Kidney Disease Not on DialysisCompletedNCT00559273Phase 3Results posted
• Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney DiseaseCompletedNCT00552409Phase 2/3Results posted
• Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease PatientsCompletedNCT00548691Phase 3Results posted
• A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With HyperphosphatemiaCompletedNCT00542815Phase 3Results posted
• A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and DyslipidaemiaCompletedNCT00542386Phase 3Results posted
• Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)CompletedNCT00509262Phase 3Results posted
• A Phase 3, Randomized, Double Blind, Placebo-Controlled, Multi-Center, Withdrawal Study of MCI-196 in CKD on Dialysis With HyperphosphatemiaCompletedNCT00506441Phase 3Results posted
• The Effect of Somatropin Treatment in Adult Patients on Chronic DialysisTerminatedNCT00503698Phase 3Results posted
• A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)CompletedNCT00501046Phase 3Results posted
• A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)CompletedNCT00500682Phase 3Results posted
• The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4CompletedNCT00497146Phase 3Results posted
• The Effect of Phototherapy on Pruritus of Patients With Chronic Kidney DiseaseCompletedNCT00494975Not applicableResults posted
• A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Participants With Chronic Kidney Disease.TerminatedNCT00462384Phase 3Results posted
• Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD (EU)TerminatedNCT00453973Phase 2Results posted
• A Study of Subcutaneous Mircera in Patients With Chronic Kidney Disease, Not on Dialysis.CompletedNCT00442702Phase 3Results posted
• Head to Head Study Against Sevelamer HydrochlorideCompletedNCT00441545Phase 3Results posted
• An Efficacy and Safety Study of Epoetin Alfa for Initiation and Maintenance Treatment of Patients With Anemia Associated With Chronic Kidney DiseaseCompletedNCT00440557Phase 3Results posted
• Low Phosphate Diets in Patients With Early Stages of Chronic Kidney DiseaseCompletedNCT00438932Not applicableResults posted
• Study to Assess Darbepoetin Alfa Dosing for the Correction of Anemia in Pediatric Patients With Chronic Kidney DiseaseTerminatedNCT00436748Phase 3Results posted
• Peginesatide for Maintenance Treatment of Anemia in Participants on HemodialysisCompletedNCT00434330Phase 2Results posted
• Study of Protective Effects of Paricalcitol on Inner Layer of Vessels and Its Protective Effect on InflammationCompletedNCT00428246Not applicableResults posted
• Cholecalciferol (Vitamin D3) Therapy in Chronic Kidney Disease (CKD) SubjectsCompletedNCT00427037Not applicableResults posted
• A Study Comparing Mircera and Epoetin Alfa for the Treatment of Anemia in Dialysis Patients With Chronic Kidney Disease.TerminatedNCT00422513Phase 3Results posted
• The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System InhibitorsCompletedNCT00421733Phase 2Results posted
• A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With HyperphosphatemiaCompletedNCT00416520Phase 3Results posted
• Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD PatientsCompletedNCT00395291Not applicableResults posted

← Renal Insufficiency, Chronic overview